Making the Case for Metabolic Surgery in Patients with Obesity and T2DM

14.08.201708.05.2020 Editor_1 2484 просмотров

Join Drs. Rachel Batterham, Carel W. Le Roux and Marco Bueter as they discuss the latest news for treatment of bariatric patients with type 2 diabetes mellitus.

Rachel Batterham

MD, MBBS, PhD, FRCP

Professor, Obesity, Diabetes and Endocrinology, University College London Hospital (UCLH); Head, UCLH/UCL National Institute of Health Research Biomedical Research Centre, London, United Kingdom

Carel W Le Roux

MBChB, MSC, FRCP, FRCPath, PhD

Professor, Imperial College London,
London, United Kingdom; Chair of Experimental Pathology, Professor,University College Dublin, Dublin, Ireland

Marco Bueter

MD, PhD

Professor, Head of Program for Bariatric and Metabolic Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerlan

Making the Case for Metabolic Surgery in Patients with Obesity and T2DM

Target Audience

This educational activity is intended for an international audience of non-US healthcare professionals, specifically diabetologists and endocrinologists, surgeons and primary care physicians involved in the treatment of patients with type 2 diabetes mellitus (T2DM).

Learning Objectives

Upon completion of this activity, participants will have increased knowledge regarding the:

• Science supporting bariatric interventions in the management of obesity and T2DM

• Clinical trial data for metabolic / bariatric surgery in the management of patients with obesity and T2DM

• Utility of metabolic / bariatric surgery vs the long-term risks of suboptimal treatment of obesity and T2DM

Purpose / Goal

The goal of this activity is to improve awareness of bariatric surgery vs pharmacotherapy in weight reduction and T2DM management, and in particular risk and benefits, and
clinical data.

Accreditation Statement

The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).